Search

Your search keyword '"Biringer K"' showing total 112 results

Search Constraints

Start Over You searched for: Author "Biringer K" Remove constraint Author: "Biringer K" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
112 results on '"Biringer K"'

Search Results

1. Systemic Lupus Erythematosus Treatment in Pregnancy: Case Study

6. Interaction of cervical microbiome with epigenome of epithelial cells: Significance of inflammation to primary healthcare

8. Perivascular epithelioid cell tumors of the uterine cervix.

9. Activity of coagulation factor XI in patients with spontaneous miscarriage: the presence of risk alleles.

25. Aronia melanocarpa L. fruit peels show anti-cancer effects in preclinical models of breast carcinoma: The perspectives in the chemoprevention and therapy modulation.

26. Droplet digital PCR analysis of CDH13 methylation status in Slovak women with invasive ductal breast cancer.

27. Evaluating Thromboprophylaxis Strategies for High-Risk Pregnancy: A Current Perspective.

28. Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells - A potential contribution to the predictive, preventive, and personalized medicine.

29. Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells.

30. Association of FSHR and DENND1A polymorphisms with polycystic ovary syndrome: a meta-analysis.

31. Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management-Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine.

32. Exploring the Bioactive Mycocompounds (Fungal Compounds) of Selected Medicinal Mushrooms and Their Potentials against HPV Infection and Associated Cancer in Humans.

33. HPV-Associated Breast Cancer: Myth or Fact?

34. DNA Polymorphisms in Pregnant Women with Sticky Platelet Syndrome.

35. Is the Physiological Composition of the Vaginal Microbiome Altered in High-Risk HPV Infection of the Uterine Cervix?

36. Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine.

37. Flavonoids exert potential in the management of hypertensive disorders in pregnancy.

38. Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care.

39. Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine.

40. Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care.

41. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person.

42. Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression-3PM pathways.

43. Placental pathology concerning sudden foetal demise in SARS-CoV-2 positive asymptomatic pregnant female.

44. Fatigue as the limiting factor for vaginal birth in patients with multiple sclerosis.

45. Recurrent Giant Malignant Phyllodes Tumor of the Breast.

46. Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021.

47. Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention.

48. Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects-the evidence-based 3PM proposition to mitigate individual risks.

49. Comedo-like skin metastases in cervical carcinoma.

50. Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects.

Catalog

Books, media, physical & digital resources